Company profile

Quantum Genomics is a biotechnology company that specializes in the research and development of drugs for the treatment of cardiovascular diseases such as high blood pressure and heart failure.

Source: Cofisem - Last Update: 13 Dec 2019
Key Executives
Chief Executive Officer Jean-Philippe Milon
Vice President Finance Marc Karako
Director Research & Development Fabrice Balavoine
Source: Cofisem - Last Update: 09 Apr 2019
Key figures
Millenium 2018 2017 2016 2015 2014
Net sales 6 12
Consumed purchases 301 773 256 156
Payroll 2,403 2,456 1,823 1,600 1,302
Operating profit -13,598 -10,292 -6,216 -4,310 -2,418
Income tax -1,458 -1,150 -958 714 -335
Net income -11,990 -9,381 -5,241 -3,764 -2,207
Fiscal year end 12.18 12.17 12.16 12.15 12.14
Length of fiscal year (month) 12 12 12 12 12
Currency & Unit EUR - thousands EUR - thousands EUR - thousands EUR - thousands EUR - thousands
Account Standards
Source: Cofisem - Last Update: 13 Dec 2019
Shareholder information
Free float 74.90 %
Institutional Funds 11.20 %
Managers 7.80 %
Tethys 6.10 %
Source: Cofisem - Last Update: 02 Apr 2019

Address

Quantum Genomics

33 Rue Marbeuf
FR-75008 Paris
France
Source: Cofisem - Last Update: 13 Dec 2019

Contact

Marc Karako
Phone number: +33 (0)1 85 34 77 75
Source: Quantum Genomics - Last Update: 13 Dec 2019